Bestatin Induces Specific Changes in Trypanosoma cruzi Dipeptide Pool

@article{Trochine2015BestatinIS,
  title={Bestatin Induces Specific Changes in Trypanosoma cruzi Dipeptide Pool},
  author={Andrea Trochine and Darren John Creek and Paula Faral-Tello and Michael P. Barrett and Carlos Robello},
  journal={Antimicrobial Agents and Chemotherapy},
  year={2015},
  volume={59},
  pages={2921 - 2925}
}
ABSTRACT Proteases and peptidases in Trypanosoma cruzi are considered potential targets for antichagasic chemotherapy. We monitored changes in low-mass metabolites in T. cruzi epimastigotes treated with bestatin, a dipeptide metalloaminopeptidase inhibitor. After treatment, multiple dipeptides were shown to be increased, confirming in situ inhibition of the leucine aminopeptidase of T. cruzi (LAPTc) and probably other peptidases. 
Development of a High-Throughput Screening Assay to Identify Inhibitors of the Major M17-Leucyl Aminopeptidase from Trypanosoma cruzi Using RapidFire Mass Spectrometry
TLDR
It is suggested that RapidFire MS is highly suitable for screening for specific LAPTc inhibitors, and developed and optimized Leu-7-amido-4-methylcoumarin–based fluorogenic assay and a RapidFire mass spectrometry (RapidFire MS)–based assay using the LSTVIVR peptide as substrate. Expand
Structural Characterization of Acidic M17 Leucine Aminopeptidases from the TriTryps and Evaluation of Their Role in Nutrient Starvation in Trypanosoma brucei
TLDR
The results suggest that in T. brucei, LAP-A may participate in protein degradation associated with nutrient depletion related to leucine depletion and subcellular localization studies performed under starvation conditions suggest a possible function of Lap-A in the response to nutrient restriction. Expand
High-Level Expression in Escherichia coli, Purification and Kinetic Characterization of LAPTc, a Trypanosoma cruzi M17-Aminopeptidase
TLDR
The recombinant LAPTc enzyme is insensitive toward the protease inhibitors PMSF, TLCK, E-64 and pepstatin A, but is inhibited by EDTA and bestatin. Expand
Expression in Escherichia coli, purification and kinetic characterization of LAPLm, a Leishmania major M17-aminopeptidase.
TLDR
It is suggested that rLAPLm is a suitable target for inhibitor identification because it is insensitive towards the protease inhibitors PMSF, TLCK, E-64 and pepstatin A, being inhibited by EDTA and bestatin. Expand
Propriedades estruturais e vibracionais dos dipeptídeos L-alanil-L-fenilalanina e L,L-dileucina
No presente trabalho os dipeptideos hidrofobicos L-alanil-L-fenilalanina (C12H16N2O3) e L,L-dileucina hidratado (C12H24N2O3·0,87H2O) foram estudados utilizando tecnicas de espectroscopia Raman eExpand

References

SHOWING 1-10 OF 31 REFERENCES
Benznidazole Biotransformation and Multiple Targets in Trypanosoma cruzi Revealed by Metabolomics
Background The first line treatment for Chagas disease, a neglected tropical disease caused by the protozoan parasite Trypanosoma cruzi, involves administration of benznidazole (Bzn). Bzn is aExpand
Metacaspases, autophagins and metallocarboxypeptidases: potential new targets for chemotherapy of the trypanosomiases.
TLDR
Proteases from protozoan parasites, including two eukaryote homologues of the carboxypeptidases Taq are promising targets due to their particular phylogenetic distribution and the increasing knowledge of their biochemical properties, including substrate specificity, crystal structure, and biological functions, is an essential step towards the development of inhibitors. Expand
The major leucyl aminopeptidase of Trypanosoma cruzi (LAPTc) assembles into a homohexamer and belongs to the M17 family of metallopeptidases
TLDR
LAPTc is a 330-kDa homohexameric metalloaminopeptidase expressed by all T. cruzi forms and mediates the major parasite leucyl aminopeptids activity, which has a strong dependence on neutral pH, is mesophilic and retains its oligomeric form up to 80°C. Expand
Cloning and Characterization of a Leucyl Aminopeptidase from Three Pathogenic Leishmania Species*
TLDR
Lap assembled into catalytically competent 360-kDa hexamers and demonstrated potent amidolytic activity against synthetic aminopeptidase substrates containing leucine, methionine, and cysteine residues, representing the most restricted substrate specificity of any leucyl aminopedidase described to date. Expand
Development of Plasmodium falciparum protease inhibitors in the past decade (2002-2012).
TLDR
Development of P. falciparum protease inhibitors is a promising approach to antimalarial chemotherapy, as highlighted by the present review which is focused on the Medicinal Chemistry research effort recorded in the past decade in this particular field. Expand
Bestatin, an inhibitor of aminopeptidase B, produced by actinomycetes.
papain, chymotrypsin, elastase, acid protease and thermolysin have been found in culture filtrates of actinomycetes. Recently we found that exopeptidases have a strong effect on mammalian cellExpand
Multi-analytical platform metabolomic approach to study miltefosine mechanism of action and resistance in Leishmania
TLDR
In resistant parasites an increase in the levels of amino acids was the most outstanding feature, probably related to the adaptation of the resistant strain for its survival inside the parasitophorous vacuole. Expand
Identification of proteases that regulate erythrocyte rupture by the malaria parasite Plasmodium falciparum.
TLDR
A forward chemical genetic screen using a highly focused library of more than 1,200 covalent serine and cysteine protease inhibitors to identify compounds that block host cell rupture by P. falciparum suggests that two mechanistically distinct proteases function to regulate processing of downstream substrates required for efficient release of parasites from host red blood cells. Expand
Fingerprinting the Substrate Specificity of M1 and M17 Aminopeptidases of Human Malaria, Plasmodium falciparum
TLDR
Specific substrate and mechanistic information important for understanding the function of these aminopeptidases are provided and could be exploited in the design of new inhibitors to specifically target these for anti-malaria treatment. Expand
Untargeted Metabolomics Reveals a Lack Of Synergy between Nifurtimox and Eflornithine against Trypanosoma brucei
TLDR
Eflornithine revealed the expected changes to the polyamine pathway as well as several unexpected changes that point to pathways and metabolites not previously described in bloodstream form trypanosomes, including a lack of arginase activity and N-acetylated ornithine and putrescine. Expand
...
1
2
3
4
...